Wilmington Savings Fund Society FSB Has $1.75 Million Holdings in The Allstate Co. (NYSE:ALL)

Wilmington Savings Fund Society FSB increased its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 457.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,249 shares of the insurance provider's stock after acquiring an additional 7,590 shares during the period. Wilmington Savings Fund Society FSB's holdings in Allstate were worth $1,754,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. OFI Invest Asset Management acquired a new position in Allstate during the 2nd quarter worth $476,000. Eagle Asset Management Inc. grew its position in shares of Allstate by 38.0% during the third quarter. Eagle Asset Management Inc. now owns 10,497 shares of the insurance provider's stock worth $2,067,000 after buying an additional 2,888 shares in the last quarter. Bank of Montreal Can increased its stake in shares of Allstate by 1.7% during the third quarter. Bank of Montreal Can now owns 683,574 shares of the insurance provider's stock worth $128,758,000 after buying an additional 11,195 shares during the period. Blueshift Asset Management LLC acquired a new stake in Allstate in the third quarter valued at approximately $623,000. Finally, Hsbc Holdings PLC lifted its stake in Allstate by 3.3% in the second quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider's stock worth $160,948,000 after acquiring an additional 31,789 shares during the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Allstate Stock Performance

Shares of ALL traded up $3.96 during mid-day trading on Friday, reaching $196.26. 1,802,975 shares of the company's stock traded hands, compared to its average volume of 1,550,028. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The Allstate Co. has a 12 month low of $134.17 and a 12 month high of $209.88. The business's 50-day moving average price is $194.95 and its 200-day moving average price is $181.30. The stock has a market capitalization of $51.97 billion, a P/E ratio of 12.71, a price-to-earnings-growth ratio of 1.70 and a beta of 0.50.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same quarter last year, the firm posted $0.81 EPS. The business's revenue for the quarter was up 14.7% on a year-over-year basis. Equities analysts predict that The Allstate Co. will post 16.26 earnings per share for the current year.

Allstate Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.88%. The ex-dividend date of this dividend is Friday, November 29th. Allstate's dividend payout ratio (DPR) is presently 23.83%.

Insiders Place Their Bets

In related news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company's stock, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.80% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. UBS Group increased their price objective on shares of Allstate from $216.00 to $225.00 and gave the company a "buy" rating in a research report on Monday, November 4th. Wells Fargo & Company increased their target price on Allstate from $175.00 to $186.00 and gave the company an "equal weight" rating in a report on Tuesday, November 5th. TD Cowen lifted their price target on Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a report on Tuesday, September 3rd. Morgan Stanley increased their price objective on Allstate from $220.00 to $228.00 and gave the company an "overweight" rating in a report on Thursday, November 7th. Finally, Jefferies Financial Group raised their target price on Allstate from $231.00 to $267.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $217.19.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.